#USA #Lexington #Cognition Corporation #Compass MED #Medical Device Development

Cognition Corporation Introduces Compass MED 3.0

Cognition Corporation has made significant strides in assisting the medical device industry with the release of its latest platform, Compass MED 3.0. This update represents a major improvement in the design control and risk management tools available to developers in the life sciences sector. By addressing common pitfalls that often hinder the Design and Development File (DDF), Cognition aims to enhance efficiency and reliability in medical device development.

Key Features of Compass MED 3.0

Automated Impact Assessment

One of the standout features of Compass MED 3.0 is its automated impact assessment capability. This tool streamlines change management within the DDF by initiating impact evaluations automatically when changes to controlled items occur. It identifies suspect links and provides comprehensive upstream and downstream context to ensure that teams are fully aware of all potential implications of any modifications. Moreover, there is an approval gate that holds unresolved impacts until they are fully assessed and electronically cleared, ensuring that all action items are recorded and tracked to conclusion.

Enhanced Test Management

Another improvement in Compass MED 3.0 is its enhanced test management module. This upgrade allows verification and validation (VV) teams to operate more efficiently through flexible test campaigns. Developers can define certain protocols, outline which requirements are verified, and designate qualified individuals to execute the tests. The system also facilitates detailed documentation of deviations and defects during the execution phase, ensuring thorough traceability for compliance with regulatory standards like 21 CFR Part 11.

Tag-Based Project Variants

Tag-based project variants offer a new way for teams to manage intricate system and subsystem development projects. Instead of duplicating entire projects, users can simply select the relevant content using tags to establish a new variant. This not only saves time and resources but also maintains traceability back to the original source data, ensuring compliance and control throughout the development process.

Seamless Integration with Azure DevOps and Jira

Compass MED 3.0 is designed to integrate effectively with popular tools such as Azure DevOps and Jira. It facilitates the automatic synchronisation of data, including requirements, test cases, and defects, on a scheduled basis, upon specific events, or on demand. This ensures that both software development teams and quality assurance teams work with consistent and synchronized data.

Optimizing Medical Device Development

With these advancements, Compass MED 3.0 underscores Cognition Corporation's commitment to promoting connected and compliant product development. The platform enables cross-functional teams to accelerate their workflows while ensuring they remain audit-ready through comprehensive data management and documentation practices.

Customer Feedback

Users have noted that the improved infrastructure of Compass MED supports best practices in risk management, adherence to clinical standards, and the maintenance of design control. As Aaron Joseph, Principal Consultant at Sunstone Pilot, remarked, the software's capabilities are well-aligned with the needs of medical device companies, illustrating Cognition's dedication to addressing industry-specific challenges.

Conclusion

As Cognition Corporation continues to innovate, the release of Compass MED 3.0 indicates a pivotal shift in how medical device developers can approach their work. It not only enhances their efficiency but also maintains stringent compliance standards, thereby reducing risks associated with device development. For more information or to schedule a demo, interested parties can visit Cognition's website or reach out directly via email.

Cognition Corporation remains at the forefront of delivering targeted solutions that streamline development processes and foster compliance in the competitive landscape of medical technology.